Monday, March 11, 2013 4:50:04 PM
Not news.
That doesn't make KBLB a successful business.
And, it doesn't refute the literature pointing out the problems with their approach... which problems are not AMSilk's creation, but FACTS quoted in the articles, which are not AMSilk's publications, but peer reviewed articles they've quoted.
AMSilk was HONEST in referencing the scientific literature while conducting a survey of the field... that was equally as honest in addressing the issues they face in working on the approach they've taken, as it was in addressing problems that KBLB has found it convenient to not mention. It's only KBLB that dissembles about the FACTS... while denying there's any problems.
The references to the peer reviewed literature are included. Look them up. The effort in denial of the facts re the literature... is telling. If KBLB could refute the content... they would... but, since they can't ?
That leaves them instead opting to posture as "successfully refuting" arguments no one is bothering with making.
No one said you can't make recombinant worms... that also make silk.
KBLB is in denial about problems... just like they've always been.
And, KBLB hasn't ever admitted there WERE problems, much less proven they have overcome them, or devised a method for creating a product... that doesn't suffer from all of the weaknesses inherent in their approach.
The key issue there... is the dishonest approach.
Can you trust them ?
You can't trust them to be honest about the science.
You can't trust them to be honest about the problems.
You can't trust them to be honest... period.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM